Showing 721-730 of 5319 results for "".
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.Ask an Expert: What is the Role of Dermatology Hospitalists?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-april-2019/19599/Helena Pasieka, MD, MS talks to host Adam Friedman, MD about the important role dermatologists can play in supporting patient care in the hospital setting. Consulting dermatologists in the hospital setting change the diagnosis up to 50% of the time!Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.Expert Spotlight: Michael Werner
https://practicaldermatology.com/topics/practice-management/expert-spotlight-michael-werner/20722/Despite passage of the SIA, no new sunscreen ingredients have been approved in the US.Systemic Effects of UV Radiation: The Case for Apoptosis of Peripheral Blood Mononuclear Cells
https://practicaldermatology.com/topics/general-topics/PD0709_11-php/22806/Mechanisms of UV-mediated tumorigenesis and development are not fully understood. Findings suggest apoptosis of peripheral blood mononuclear cells may play a role.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dHarnessing Psychology to Make Your Practice and Outside Life Better
https://practicaldermatology.com/topics/editorial/harnessing-psychology-make-your-practice-and-outside-life-better/26952/Harnessing Psychology to Make Your Practice and Outside Life BetterThe Landscape of Vitiligo Treatment
https://practicaldermatology.com/series/updates-vitiligo/the-landscape-of-vitiligo-treatment/24467/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Lawrence Green, MD, a dermatologist practicing in Rockville, MD, about the landscape of treatments for patients with vitiligo and new therapies that may be coming from ongoing clinical trials.Physician Spotlight: Chérie M. Ditre, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-chrie-m-ditre-md/20740/The skinny on what's new and exciting in cosmetic dermatology.DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-factors-affecting-long-term-antibiotic-prescriptions-acne-biologics-firm-focusing-plaque-psoriasis-makes-important-acquisition-practical-dermatology-launches-two-new-video-series/24319/In this episode of DermWire TV, a new analysis highlights factors affecting long-term antibiotic prescriptions for acne; a company developing plaque psoriasis biologics makes a major acquisition; and Practical Dermatology® launches two new video series focusing on advancing treatment and improving u